Clinical Trials Directory

Trials / Completed

CompletedNCT00005761

Blood Factors and Diabetic Retinopathy

Study of Association of Serum Factors With Diabetic Retinopathy

Status
Completed
Phase
Study type
Observational
Enrollment
173 (actual)
Sponsor
National Eye Institute (NEI) · NIH
Sex
All
Age
10 Years
Healthy volunteers
Not accepted

Summary

This study will determine whether certain factors in the blood are associated with the severity of diabetic retinopathy. Patients age 10 years and older with diabetes mellitus and diabetic retinopathy may be eligible for this study. Those enrolled will represent a range of diabetic retinopathy from minimal to severe. Participants will undergo the following procedures: * medical history * thorough eye examination * photographs of the eye * blood tests to measure blood lipids (cholesterol and triglycerides) and serum creatinine (for kidney function) * blood tests to measure levels of blood factors (cell adhesion molecules, chemokines and vascular endothelial growth factor) that may be related to the progression of diabetic retinopathy * blood pressure measurement * urinalysis This study may lead to a better understanding of how diabetic retinopathy develops and progresses.

Detailed description

Participants with a range of severity of diabetic retinopathy and healthy volunteers will be evaluated once for serum levels of cell adhesion molecules, chemokines and vascular endothelial growth factor. This study may lead to a better understanding of the pathogenesis of diabetic retinopathy and the identifying of possible targets for treatment. All study participants will undergo an ocular exam and ophthalmic photography. Blood is drawn for the analysis of these serum factors.

Conditions

Timeline

Start date
2000-05-23
Completion
2010-12-07
First posted
2000-05-29
Last updated
2017-07-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00005761. Inclusion in this directory is not an endorsement.